Bladder cancer: open trials in Switzerland

10 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Inselspital Bern - Universitätsklinik für Medizinische Onkologie, Bern · Hopitaux Universitaires de Geneve - Oncology Department, Geneva · UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie, Zurich
Registry updated 2026-11-04
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Chur · Sankt Gallen · Winterthur
Registry updated 2026-10-01
NCT06227065
Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids
Trial Treatment · Phase 2 · Hospital Centre Biel/Bienne
Lindenhofspital, Klinik für Urologie, Bern · Spitalzentrum Biel, Klinik für Urologie, Biel
Registry updated 2026-09-18
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Ospedale Regionale Bellinzona e Valli, Bellinzona · Kantonsspital Graubunden, Chur · Cantonal Hospital St Gallen, Sankt Gallen · Universitätsspital Zürich, Zurich
Registry updated 2026-07-29
NCT07705074
FAPI PET Imaging - An Exploratory Study
Trial Treatment · Phase 1/2 · Martin Huellner
Kantonsspital Baden, Baden · Hôpitaux Universitaires de Genève (HUG), Geneva · Clinique de Genolier, Genolier · Luzerner Kantonsspital, Lucerne · Department for Nuclear Medicine, University Hospital Zurich, Zurich
Registry updated 2026-07-15
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Kantonsspital Graubunden, Chur · University Hospital Lausanne, CHUV, Lausanne · CHUV - Service de pharmacie BH-04, Essais cliniques, Lausanne
Registry updated 2026-07-06
NCT07581496
T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer
Research · University Hospital, Basel, Switzerland
Universitätsspital Basel, Basel · Luzerner Kantonsspital, Lucerne
Registry updated 2026-05-18
NCT07494864
Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Research · University of Zurich
Balgrist University Hospital, Zurich
Registry updated 2026-03-27
NCT05726786
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Trial Treatment · Phase 3 · Centre Hospitalier Universitaire Vaudois
University Hospital of Bern, Bern · University Hospital of Geneva, Geneva · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne · Hospital of Riviera-Chablais, Rennaz
Registry updated 2025-12-09
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Inselspital, Bern · Universitaetsspital Zürich, Zurich
Registry updated 2024-08-26

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error